Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Shuttle Pharmaceuticals Holdings Inc (SHPH)

Shuttle Pharmaceuticals Holdings Inc (SHPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program GlobeNewswire - Thu Dec 19, 8:00AM CST

SHPH : 0.7710 (+7.83%)
Shuttle Pharmaceuticals Announces First Patient Enrollment in Phase 2 Clinical Trial of Ropidoxuridine for Glioblastoma Treatment at UVA Cancer Center Quiver Quantitative, Inc. - Tue Nov 26, 6:24PM CST

Shuttle Pharma enrolls first patient in Phase 2 trial for Ropidoxuridine, targeting glioblastoma treatment at UVA Cancer Center.Quiver AI SummaryShuttle Pharmaceuticals Holdings, Inc. has announced the...

SHPH : 0.7710 (+7.83%)
Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient GlobeNewswire - Tue Nov 26, 8:00AM CST

SHPH : 0.7710 (+7.83%)
Shuttle Pharmaceuticals Holdings, Inc. Advances Phase 2 Clinical Trial for Ropidoxuridine in Glioblastoma Treatment Quiver Quantitative, Inc. - Thu Nov 14, 2:56AM CST

Shuttle Pharmaceuticals reports progress in its Phase 2 trial of Ropidoxuridine for glioblastoma and financial updates.Quiver AI SummaryShuttle Pharmaceuticals Holdings, Inc. has announced significant...

SHPH : 0.7710 (+7.83%)
Shuttle Pharma Provides Third Quarter 2024 Corporate Update GlobeNewswire - Wed Nov 13, 4:00PM CST

SHPH : 0.7710 (+7.83%)
Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News wealthyventurecapitalist.com - Tue Nov 12, 6:19PM CST

Shuttle Pharmaceuticals (NASDAQ: SHPH), a rising force in cancer treatment innovation, has experienced a notable boost in its stock price following a recent wave of positive developments. Shares of Shuttle...

SHPH : 0.7710 (+7.83%)
Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News wealthyventurecapitalist.com - Wed Oct 30, 11:40PM CDT

Shuttle Pharmaceuticals (NASDAQ: SHPH), a rising force in cancer treatment innovation, has experienced a notable boost in its stock price following a recent wave of positive developments. Shares of Shuttle...

SHPH : 0.7710 (+7.83%)
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules GlobeNewswire - Tue Oct 29, 8:05PM CDT

SHPH : 0.7710 (+7.83%)
Shuttle Pharma Pays Off Senior Secured Convertible Note GlobeNewswire - Tue Oct 29, 3:05PM CDT

SHPH : 0.7710 (+7.83%)
Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma GlobeNewswire - Tue Oct 29, 8:00AM CDT

SHPH : 0.7710 (+7.83%)

Barchart Exclusives

3 AI Stocks That Could Each Be Worth $4 Trillion in 2025 Barchart - Wed Dec 25, 6:30AM CST
AI giants Apple, Microsoft, and Nvidia leverage groundbreaking technologies and strong financial growth, positioning themselves as top contenders for $4 trillion market caps by 2025. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot